Active Shortage

APO-ARIPIPRAZOLE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-ARIPIPRAZOLE in Canada?

Yes. APO-ARIPIPRAZOLE 20MG has an active shortage reported to Health Canada (last updated September 18, 2026).

Why is APO-ARIPIPRAZOLE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-ARIPIPRAZOLE be available again?

The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Expected resolution~18 days remaining (estimate)

Affected strength20MG

Last updated2026-09-18

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ABILIFY

OTSUKA PHARMACEUTICAL CO LTD

20MG · DIN 02322412

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MINT-ARIPIPRAZOLE

MINT PHARMACEUTICALS INC

20MG · DIN 02483599

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

AG-ARIPIPRAZOLE

ANGITA PHARMA INC.

2MG · DIN 02448173

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-ARIPIPRAZOLE

AURO PHARMA INC

15MG · DIN 02460068

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-ARIPIPRAZOLE

PHARMASCIENCE INC

30MG · DIN 02466694

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ ARIPIPRAZOLE

SANDOZ CANADA INCORPORATED

30MG · DIN 02473704

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-16

~18 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02471124

Strength

20MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ARIPIPRAZOLE

Tier

Unrated

Last Updated

2026-09-18

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-ARIPIPRAZOLE has 2 shortage/discontinuation reports on file — this is one of them.

2026-09-18

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244